Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gene expression study of Metvix PDT in renal transplant patients with field actinic keratosis
2008-001603-30Phase 4Completed
- Sponsor
- Galderma
- Start
- Aug 2008
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methyl aminolevulinate in actinic keratosis (AK), sponsored by Galderma. Started Aug 2008; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2008-001603-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001603-30.